A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TD / transdermal

[Related PubMed/MEDLINE]
Total Number of Papers: 44
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TD  (>> Co-occurring Abbreviation)
Long Form:   transdermal
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A population-based study of transdermal fentanyl initiation in Australian clinical practice. AOR
2019 Different routes and formulations of melatonin in critically ill patients. A pharmacokinetic randomized study. AUC, muE, SLN-OS
2019 Pharmacokinetics and pharmacodynamics of intravenous and transdermal flunixin meglumine in alpacas. PGE2, PK
2019 Pharmacokinetics and pharmacodynamics of intravenous and transdermal flunixin meglumine in meat goats. PGE2, PK
2019 Pharmacokinetics of transdermal flunixin in sows. AUC, FM, PK
2018 A Comparative Study of Transdermal Buprenorphine and Oral Morphine in the Treatment of Chronic Pain of Malignant Origin. ---
2018 Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine. BBR, DBG, DHB
2018 Is There a Difference between Ultrasonographic (US) Uterine Changes of Oral Versus Transdermal (TD) 17beta Estradiol (17beta E2) in Girls with Turner Syndrome (TS)? Own Experience and Literature Review. TS, US, US
2018 Opioid Medications in Expensive Formulations Are Sold at a Lower Price than Immediate-Release Morphine in Countries throughout the World: Third Phase of Opioid Price Watch Cross-Sectional Study. EML, IR, OPW, SR
10  2018 Penetration and efficacy of transdermal NSAIDs in a model of acute joint inflammation. DEL, GI, NSAIDs
11  2017 Methacrylate-Stitched beta-Cyclodextrin Embedded with Nanogold/Nanotitania: A Skin Adhesive Device for Enhanced Transdermal Drug Delivery. beta-CD, IP, TNT, WVP
12  2017 Pharmacokinetics of intravenous and transdermal fentanyl in alpacas. i.v
13  2017 Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review. WHO
14  2016 Fabrication of a bioadhesive transdermal device from chitosan and hyaluronic acid for the controlled release of lidocaine. AHA, BMA, CS, GMA, HA, LD
15  2015 Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain. CR, OFL
16  2015 Transdermal microemulsions of Boswellia carterii Bird: formulation, characterization and in vivo evaluation of anti-inflammatory activity. AKBA, BC, MEs
17  2014 A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain. IM, NNT, RR, SC, SL
18  2013 A cross-sectional survey of pain in palliative care in Portugal. PMI
19  2013 Metabolic effects of oral versus transdermal 17beta-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome. TS
20  2013 Safety and efficacy of transdermal buprenorphine for the relief of cancer pain. CI, RCTs, RR
21  2013 Switching from high doses of pure mu-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study. ---
22  2013 The effect of transdermal opioid use on breakthrough opioid and sedative prescribing for rural patients with chronic pain in Northwest Tasmania: a longitudinal study. CI, CNCP, IR, SR
23  2012 Do transdermal opioids affect the personal socioeconomic costs of healthcare access in an australian rural pain population? A comparison with oral opioids. CI, CNCP, MHT
24  2011 Antinociceptive efficacy and plasma concentrations of transdermal buprenorphine in dogs. TT
25  2010 Low doses of transdermal fentanyl in opioid-naive patients with cancer pain. ---
26  2009 Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach. CNS, GSS, ICER, QALY, SHI
27  2009 Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study. ---
28  2008 Microneedles permit transdermal delivery of a skin-impermeant medication to humans. MNs, NTX, SC
29  2008 Rivastigmine transdermal patch: role in the management of Alzheimer's disease. GI
30  2008 Transdermal lovastatin enhances fracture repair in rats. LV
31  2007 Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome. ---
32  2006 Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany. ---
33  2006 The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron. PONV
34  2006 Transdermal oxybutynin in the treatment of overactive bladder. OXY
35  2005 Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study. WHO
36  2005 Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study. ---
37  2003 Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. PLO gel
38  2003 Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. APC, CPA, EE
39  1998 Development and in vivo assessment of a transdermal system for physostigmine. PHY
40  1997 Effect of vehicles and penetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairless mouse skin. IPA, MTX, PG, RA
41  1995 Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery. AChE, PK-PD
42  1994 Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. i.v
43  1993 [The noninvasive quantitative evaluation of the acute hemodynamic effects of sublingual and transdermal nitroglycerin in man]. NTG
44  1988 Cue properties of oral and transdermal nicotine in the rat. ---